All News

Earlier this year, the FDA granted accelerated approval to tepotinib (Tepmetko, EMD Serono Inc) for the treatment of adults with metastatic non-small cell lung cancer who are harboring MET exon 14 skipping alterations.

Prior to this research, it was known that genetically removing the POLQ protein killed cells with BRCA gene defects, but no drug had been identified that prevented POLQ from functioning.

Jordan Tishler, MD, president of the Association of Cannabis Specialists and faculty at Harvard Medical School, discusses the importance of unbiased, knowledgeable providers being present at the site of sale of cannabis in order to provide accurate information on the appropriate use of medical cannabis for certain medical conditions.

Intravenous immunoglobulin is a cornerstone in autoimmune disease treatment.

The findings showed that 63 of the 9119 patients with severe COVID-19 infection contracted the virus a second time, with an average reinfection period of 116 days.

Positive topline results have been published from a phase 3 trial assessing the CD-19 directed CAR T cell therapy lisocabtagene maraleucel as a second-line treatment in adults with relapsed or refractory LBCL.

Popular among European royalty, the consumption of human brain emerged in the 17th century as a cure to ailments of the mind.

The omega-3 polyunsaturated fatty acids eicosapentaenoic acid and docosahexaenoic acid were applied first in high doses to lab-grown neurons and then in patients to understand the mechanism by which they reduce inflammation and depression.

Astepro Allergy is the first steroid-free antihistamine of its kind to be available without a prescription.

Specialty medications should not be defined by their cost and should instead be defined by their efficacy.

Phase 2 clinical trial results assessing sotorasib in previously treated patients with NSCLC showed that the drug presented a median OS of 12.5 months among 124 patients.

The FDA recently approved the amyloid beta-directed antibody indicated for the treatment of the progressive disease.

Pharmacists play an important role in assisting with hypertension treatment by helping to modify blood pressure therapies when patients experience adverse effects or helping if a patient has difficulty remembering to take their medications.

The findings led to the FDA accepting the supplemental Biologics License Application and Priority Review designation for treatment, according to a Gilead press release.

The study authors examined data from the Health and Retirement Study, which included 2496 individuals who were at least 51 years of age.

Results of various studies show potentially promising clinical benefits associated with the use of supplementation in individuals who have the virus.

Home infusion within the larger ambulatory infusion setting poses specific advantages and disadvantages in relation to other available location options.

Technicians can help prevent drug diversion, provide care for patients with opioid use disorder.

A patient with multiple providers and health problems seeks a pharmacist’s knowledge for managing her prescribed and OTC drug products.

Avapritinib is approved for adult patients with advanced systemic mastocytosis, including individuals with aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, and mast cell leukemia.

Updated research offers an additional 2 years of follow-up data and statistics on treatment with a combination of ibrutinib and venetoclax in patients with chronic lymphocytic leukemia.

Susan Lang, MA, MBA, the CEO of XIL Health and former senior executive with Express Grips, discusses what might happen to independent pharmacies if things continue as they are following the financial difficulties of the pandemic.

There is ample evidence to suggest that there can be considerable variability in pharmacists’ tenacity to provide comprehensive care to patients.

A lower antibody response found in one-fourth of patients taking methotrexate does not necessarily mean that these patients are not protected against COVID-19.

Common factors that contributed to increased dissatisfaction at work included workflow disruptions, role conflict, quantity of work, organizational culture, and leadership support.

The researchers found that the effect of fatigue from sleep disruption increased among patients with diabetes.